New Omicron subvariant BQ.1.1 resistant to all therapeutic antibodies, study finds: Development of…
Are the currently approved antibody therapies used to treat individuals at increased risk for severe COVID-19 disease also effective against currently circulating viral variants? A recent study by researchers at the German Primate Center…